Medical device company Ra Medial Systems
set terms for its planned initial public offering on Monday, saying in a regulatory filing that it plans to offer 3.3 million shares priced at $14 to $16 each. The company is planning to list on the New York Stock Exchange under the ticker symbol “RMED.” Piper Jaffray and Cantor are lead underwriters on the deal, with SunTrust Robinson Humphrey, Nomura and Maxim Group acting as co-managers. The company is developing an excimer laser-based platform called DABRA for use in treating vascular and dermatological diseases. An excimer laser is a type of ultra-violet laser.
View more information: https://www.marketwatch.com/story/medical-device-company-ra-medical-systems-to-offer-33-million-shares-in-ipo-priced-at-14-to-16-each-2018-09-17